DE69122229D1 - Penciclovir enthaltende pharmazeutische formulierung - Google Patents

Penciclovir enthaltende pharmazeutische formulierung

Info

Publication number
DE69122229D1
DE69122229D1 DE69122229T DE69122229T DE69122229D1 DE 69122229 D1 DE69122229 D1 DE 69122229D1 DE 69122229 T DE69122229 T DE 69122229T DE 69122229 T DE69122229 T DE 69122229T DE 69122229 D1 DE69122229 D1 DE 69122229D1
Authority
DE
Germany
Prior art keywords
penciclovir
pharmaceutical formulation
containing pharmaceutical
formulation
pharmaceutical
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69122229T
Other languages
English (en)
Other versions
DE69122229T2 (de
Inventor
Hazel-Ann Griffiths
Alan Goodall
Smithkline Beecha Oduro-Yeboah
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis International Pharmaceutical Ltd
Original Assignee
Beecham Group PLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Beecham Group PLC filed Critical Beecham Group PLC
Application granted granted Critical
Publication of DE69122229D1 publication Critical patent/DE69122229D1/de
Publication of DE69122229T2 publication Critical patent/DE69122229T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Virology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dermatology (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Dispersion Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DE69122229T 1990-01-26 1991-01-24 Penciclovir enthaltende pharmazeutische formulierung Expired - Lifetime DE69122229T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB909001886A GB9001886D0 (en) 1990-01-26 1990-01-26 Pharmaceutical formulation
PCT/GB1991/000102 WO1991011187A1 (en) 1990-01-26 1991-01-24 Pharmaceutical formulation

Publications (2)

Publication Number Publication Date
DE69122229D1 true DE69122229D1 (de) 1996-10-24
DE69122229T2 DE69122229T2 (de) 1997-03-06

Family

ID=10669997

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69122229T Expired - Lifetime DE69122229T2 (de) 1990-01-26 1991-01-24 Penciclovir enthaltende pharmazeutische formulierung

Country Status (29)

Country Link
EP (1) EP0511991B1 (de)
JP (1) JP2545317B2 (de)
KR (1) KR0170414B1 (de)
CN (1) CN1056058C (de)
AP (1) AP197A (de)
AT (1) ATE142880T1 (de)
AU (1) AU643975B2 (de)
CA (1) CA2074503C (de)
CY (2) CY1984A (de)
DE (1) DE69122229T2 (de)
DK (1) DK0511991T3 (de)
ES (1) ES2092559T3 (de)
FI (1) FI101600B (de)
GB (1) GB9001886D0 (de)
GR (1) GR3021385T3 (de)
HK (1) HK218996A (de)
HU (1) HU215842B (de)
IE (1) IE910249A1 (de)
IL (1) IL97008A (de)
LU (1) LU90110I2 (de)
MA (1) MA22051A1 (de)
MY (1) MY110074A (de)
PL (1) PL166678B1 (de)
PT (1) PT96563B (de)
SA (1) SA91110341B1 (de)
SG (1) SG49144A1 (de)
TW (1) TW307687B (de)
WO (1) WO1991011187A1 (de)
ZA (1) ZA91525B (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9114939D0 (en) * 1991-07-11 1991-08-28 Smithkline Beecham Plc Pharmaceutical formulation
GB9326177D0 (en) * 1993-12-22 1994-02-23 Smithkline Beecham Plc Pharmaceuticals
US6124304A (en) * 1993-10-05 2000-09-26 Smithkline Beecham Plc Penciclovir for the treatment of zoster associated pain
GB9601544D0 (en) 1996-01-26 1996-03-27 Smithkline Beecham Plc Pharmaceuticals
US7223387B2 (en) 1998-11-18 2007-05-29 Medivir Ab Antiviral formulations comprising propylene glycol and an isopropyl alkanoic acid ester
WO2017029298A1 (en) 2015-08-17 2017-02-23 Sanovel Ilac Sanayi Ve Ticaret A.S. A topical antiviral composition
US11364198B2 (en) 2018-04-05 2022-06-21 Bausch Health Ireland Limited Polymeric emulsion delivery systems

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1523865A (en) * 1974-09-02 1978-09-06 Wellcome Found Purine compunds and salts thereof
KR830005852A (ko) * 1980-07-18 1983-09-14 미첼 페터 잭슨 피부와 점막의 비루스 감염치료에 적합한 국소치료제의 제조방법
GB2080106B (en) * 1980-07-18 1984-03-07 Weelcome Foundation Ltd Acyclovin preparations
EP0095813A3 (de) * 1982-06-01 1985-05-08 THE PROCTER & GAMBLE COMPANY Durchdringende topische pharmazeutische Präparate, die 9-(2-Hydroxyäthoxymethyl)-guanin enthalten
DE3485225D1 (de) * 1983-08-18 1991-12-05 Beecham Group Plc Antivirale guanin-derivate.
IL73682A (en) * 1983-12-20 1991-08-16 Medivir Ab Antiviral pharmaceutical compositions containing 9-hydroxy aliphatic derivatives of guanine,some new such derivatives and process for their preparation
EP0152316B1 (de) * 1984-01-26 1989-07-26 Merck & Co. Inc. Substituierte Butylguanine und ihre Verwendung in antiviralen Zusammensetzungen
DE3671227D1 (de) * 1985-07-27 1990-06-21 Beecham Group Plc 9-substituierte guaninmonohydrate.

Also Published As

Publication number Publication date
HU215842B (hu) 2001-02-28
SA91110341B1 (ar) 2004-05-25
KR920703060A (ko) 1992-12-17
FI923371A0 (fi) 1992-07-24
IL97008A0 (en) 1992-03-29
CY1999020I2 (en) 2009-11-04
SG49144A1 (en) 1998-05-18
CN1056058C (zh) 2000-09-06
DE69122229T2 (de) 1997-03-06
MA22051A1 (fr) 1991-10-01
ES2092559T3 (es) 1996-12-01
IE910249A1 (en) 1991-07-31
AU643975B2 (en) 1993-12-02
PT96563B (pt) 1998-07-31
AP9000236A0 (en) 1991-01-31
LU90110I2 (fr) 1997-09-25
DK0511991T3 (da) 1996-11-11
AP197A (en) 1992-06-30
FI923371A (fi) 1992-07-24
EP0511991A1 (de) 1992-11-11
FI101600B1 (fi) 1998-07-31
CA2074503A1 (en) 1991-07-27
PL166678B1 (pl) 1995-06-30
JPH05503695A (ja) 1993-06-17
ATE142880T1 (de) 1996-10-15
CA2074503C (en) 1999-12-14
EP0511991B1 (de) 1996-09-18
FI101600B (fi) 1998-07-31
PT96563A (pt) 1991-10-15
HU9202431D0 (en) 1992-10-28
CN1053547A (zh) 1991-08-07
AU7155891A (en) 1991-08-21
GB9001886D0 (en) 1990-03-28
WO1991011187A1 (en) 1991-08-08
KR0170414B1 (ko) 1999-02-18
TW307687B (de) 1997-06-11
MY110074A (en) 1997-12-31
CY1984A (en) 1997-09-05
HUT62472A (en) 1993-05-28
HK218996A (en) 1997-01-03
ZA91525B (en) 1992-02-26
GR3021385T3 (en) 1997-01-31
IL97008A (en) 1995-05-26
JP2545317B2 (ja) 1996-10-16

Similar Documents

Publication Publication Date Title
DE69231965D1 (de) Pharmazeutische formulierungen
ATA129892A (de) Pharmazeutische zusammensetzung
DE10199066I1 (de) Pharmazeutische Zusammensetzung
DE69525148D1 (de) Pharmazeutische formulierung
DE122004000023I2 (de) Pharmazeutische Zusammensetzung
DK481989A (da) Farmaceutiske formuleringer
DK0515312T3 (da) Farmaceutisk præparat
DE69101931D1 (de) Pharmazeutische Zusammensetzung.
DE4291156T1 (de) Verbesserte pharmazeutische Zusammensetzungen
KR900011476A (ko) 백신 제제
LV10573A (lv) Panemiens farmaceitiska sastava iegusanai
DE69115263D1 (de) Pharmazeutische zusammensetzungen.
DE69133371D1 (de) Pharmazeutische wirksame Benzochinazolin Verbindungen
DE3882157D1 (de) Nichtsteroide antientzuendungswirkstoffe enthaltende pharmazeutische zubereitungen.
ATA240692A (de) Pharmazeutische zusammensetzungen mit einem gehalt an ranitidinwismutcitrat
DE68918847D1 (de) Stabile pharmazeutische zusammensetzung.
DE4294862T1 (de) Pharmazeutische Komposition
DE69122229D1 (de) Penciclovir enthaltende pharmazeutische formulierung
ATA133288A (de) Pharmazeutische zusammensetzung
ATA321188A (de) Pharmazeutische zubereitung
DE68902056D1 (de) 4-aroylimidazol-2-on enthaltende pharmazeutische zusammensetzung.
DE69003003D1 (de) Pharmazeutische Zusammensetzung.
ATA31798A (de) Pharmazeutische zusammensetzung enthaltend ciclosporin
ATA246089A (de) Pharmazeutische zusammensetzung enthaltend phenylcarbamate
BR1100393A (pt) Composto e formulação farmacêutica

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: NOVARTIS INTERNATIONAL PHARMACEUTICAL LTD., HAMILT